The induction of Th1 and CD8+ T cell responses is highly desirable, forexample, in vaccines targeting either chronic viral diseases, infections linked tointracellular pathogens, cancer (therapeutic vaccines) [18] or to modulate allergy diseases [11,19]. Here, CD8A is linked to cancer.